Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland.
Piotr MerksBeata ChełstowskaUrszula ReligioniAgnieszka Neumann-PodczaskaZbigniew KrasińskiAdam KobayashiKatarzyna Plagens-RotmanEwelina DrelihKatarina Fehir-SolaŁukasz FijałkowskiIzabela BajRegis VaillancourtKatarzyna Wieczorowska-TobisAgnieszka Mastalerz-MigasMark KoziolJarosław PinkasFilip M SzymańskiDagmara HeringPublished in: Medical science monitor : international medical journal of experimental and clinical research (2024)
New Medicine Service (NMS) components are an important element to improve patient compliance with medical recommendations. NMS provides support to patients prescribed new medicines, helping them to manage long-term conditions. The purpose of this service is to provide patients with advice, guidelines, and educational materials regarding the use of new medicines to increase patient compliance and therapy safety. The NMS has already been introduced in many European countries. This review aims to identify the benefits and potential barriers to implementing the NMS in community pharmacies and to suggest solutions that would increase its effectiveness. Previous studies have primarily shown that the NMS improves patient compliance with therapy, accelerating the expected effects of the therapy. Pharmacist support during implementation of a new drug therapy substantially increases patient safety. As the experience of numerous countries shows, both pharmacists and patients express positive opinions on this service. Therefore, it seems that NMS should be an indispensable part of pharmaceutical patient care in any healthcare system. This article aims to review the implementation of the New Medicine Service (NMS) for community pharmacists in Poland and the provision of a cost-effective approach to improve patient adherence to newly-prescribed medicine for chronic diseases.
Keyphrases
- healthcare
- mental health
- patient safety
- case report
- end stage renal disease
- quality improvement
- ejection fraction
- newly diagnosed
- chronic kidney disease
- randomized controlled trial
- primary care
- prognostic factors
- systematic review
- peritoneal dialysis
- emergency department
- type diabetes
- stem cells
- mesenchymal stem cells
- adipose tissue
- insulin resistance
- clinical practice
- cell therapy
- weight loss
- bone marrow
- chemotherapy induced
- replacement therapy
- smoking cessation